The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.
MDC Connects 2021: A Guide to Complex Medicines is a series of webinars exploring the opportunities and challenges presented by this new class of medicines, and takes you through the steps to take an idea from concept to the clinic.
At this midpoint in the webinar series, we will hear from the pioneers developing complex medicines and the challenges presented and overcome.
Lipid nanoparticles – so much more than a little fat blob – Yvonne Perrie (University of Strathclyde)
“Bursting with promise” – precision drug delivery with Therapeutic Microbubbles – Louise Coletta (University of Leeds)
Under the radar: alternative delivery of mRNA vaccines – Helen McCarthy (pHion Therapeutics)